HBK Investments’s Bristol-Myers Squibb BMY Stock Holding History

HBK Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,700	Closed	-$876K	–	255
2023 Q2	$876K	Sell	13,700 -415,200	-97%	-$27.8M	﹤0.01%	281
2023 Q1	$29.7M	Buy	+428,900	New	+$30.3M	0.19%	36
2022 Q4	–	Sell	-73,800	Closed	-$5.25M	–	40
2022 Q3	$5.25M	Buy	73,800 +63,800	+638%	+$4.63M	0.04%	185
2022 Q2	$770K	Buy	+10,000	New	+$762K	﹤0.01%	417
2021 Q3	–	Sell	-59,000	Closed	-$3.94M	–	769
2021 Q2	$3.94M	Buy	59,000 +11,800	+25%	+$769K	0.01%	358
2021 Q1	$2.98M	Buy	+47,200	New	+$2.94M	0.01%	391
2020 Q4	–	Sell	-187,300	Closed	-$11.3M	–	695
2020 Q3	$11.3M	Buy	187,300 +64,500	+53%	+$3.88M	0.08%	100
2020 Q2	$7.22M	Buy	+122,800	New	+$7.35M	0.09%	128
2020 Q1	–	Sell	-67,900	Closed	-$4.36M	–	94
2019 Q4	$4.36M	Sell	67,900 -45,000	-40%	-$2.58M	0.04%	305
2019 Q3	$5.72M	Hold	112,900	–	–	0.07%	221
2019 Q2	$5.12M	Sell	112,900 -3,958,100	-97%	-$184M	0.04%	229
2019 Q1	$194M	Buy	+4,071,000	New	+$203M	1.96%	9

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HBK Investments's BMY Position: Q3 2023 in Review

HBK Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 9,760 shares — an estimated $624K sold.

HBK Investments first reported a position in BMY in Q2 2014 and held it in 16 quarters. The position peaked at $38.4M in Q2 2018. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

HBK Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
HBK Investments sold 9,760 Bristol-Myers Squibb shares in Q3 2023, an estimated $624K.
HBK Investments first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 16 quarters.
HBK Investments's Bristol-Myers Squibb position peaked at $38.4M in Q2 2018.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.